XML 44 R28.htm IDEA: XBRL DOCUMENT v3.6.0.2
Summary of Significant Accounting Policies and Recent Accounting Pronouncements (Tables)
12 Months Ended
Dec. 31, 2016
Accounting Policies [Abstract]  
Equity Method Investments
As of December 31, 2016, our investment in equity method investments comprised as follows (in thousands):
SB Oils JV (Note 4)
$
42,373

Algenist Holdings, Inc. (Note 18)
1,483

Total equity method investments
$
43,856

Property, Plant and Equipment Estimated Ranges of Useful Lives
Depreciation is calculated on a straight-line basis over the following estimated ranges of useful lives: 
Asset classification
 
Estimated useful life
Plant equipment
 
5 – 20 years
Lab equipment
 
3 – 7 years
Leasehold improvements
 
Shorter of useful life
or life of lease
Building and improvements
 
7 – 20 years
Computer equipment and software
 
3 – 7 years
Furniture and fixtures and automobiles
 
5 – 7 years
Long-lived Assets by Geographic Areas [Table Text Block]
Geographic revenues are identified by the location in which the research and development program revenue and product sales were originated, and Long-lived assets, net of accumulated depreciation were as follows (in thousands).
 
Year ended December 31,
 
2016
 
2015
 
2014
United States
$
18,036

 
$
22,454

 
$
31,845

Brazil
446

 
399

 
4,117

Total revenues
$
18,482

 
$
22,853

 
$
35,962

 
 
 
 
 
 
 
 
 
As of December 31,
 
 
 
2016
 
2015
United States
 
 
$
24,157

 
$
25,973

Brazil
 
 
42,373

 
35,933

Total long-lived assets
 
 
$
66,530

 
$
61,906

Schedule of Accumulated Other Comprehensive Income (Loss)
The components of accumulated other comprehensive income (loss) consisted of the following (in thousands):
 
Foreign Currency Translation Adjustments
 
Change in unrealized gain/loss on available-for-sale securities
 
Total Accumulated Other Comprehensive Loss
Balance at December 31, 2013
$
(3,880
)
 
$
86

 
$
(3,794
)
Current period other comprehensive loss
(6,908
)
 
(312
)
 
(7,220
)
Balance at December 31, 2014
(10,788
)
 
(226
)
 
(11,014
)
Current period other comprehensive loss
(11,545
)
 
228

 
(11,317
)
Balance at December 31, 2015
(22,333
)
 
2

 
(22,331
)
Current period other comprehensive loss
5,525

 
(2
)
 
5,523

Balance at December 31, 2016
$
(16,808
)
 
$

 
$
(16,808
)
Outstanding Shares of Potentially Dilutive Securities Excluded from Calculation of Dilutive Net Loss per Share
The following outstanding shares of potentially dilutive securities were excluded from the calculation of diluted net loss per share for the periods presented as the effect was anti-dilutive (in thousands):
 
Year ended December 31,
 
2016
 
2015
 
2014
Shares of common stock to be issued upon conversion of the Notes
15,152

 
18,791

 
18,791

Shares of common stock to be issued upon conversion of Series A Preferred Stock
13,375

 

 

Options to purchase common stock
12,707

 
11,901

 
13,740

Restricted stock units
1,274

 
1,884

 
1,812

Warrants to purchase common stock
750

 
750

 
1,250

Total
43,258

 
33,326

 
35,593